Although aspirin plus heparin remains the gold standard, clinicians will soon be able to select, from an array of antithrombotic strategies, the agents that best match the patient's hemodynamic status. Revascularization is not routinely indicated; it should be reserved for high-risk patients in whom medical therapy has failed, who have had a myocardial infarction, or who have other compromising factors.
|Original language||English (US)|
|Number of pages||12|
|State||Published - Oct 15 1997|
ASJC Scopus subject areas